RNWL
INTERNATIONAL REGISTRATION RENEWED
13/01/2026
Voltar para busca
Dado oficial do USPTO
CARTIHEAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
14/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35
Data de depósito
24/03/2015
Data de registro
19/07/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/02/2023
Última transação
14/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IL
Examinador
THOMAS,JULIE
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CARTIHEAL (2009) LTD.
Representantes
Wolff, Bregman & Goller
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances for the treatment of geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders; veterinary preparations and substances for the treatment of geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders ; medicines for the treatment of geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders; chemicalbiochemical and biological substances for medical and veterinary purposesbody and cartilage implants comprising living tissue; sanitary preparations for medical purposes; food for babies; dietary supplements for humans and animals; nutritional supplementsvitaminsmineral supplements; medical plastersmaterials for dressingsgauzemedical adhesive tapedissolvable strips to stop bleeding form minor cuts and grazes; material for stopping teethdental wax; disinfectants for hygienic purposes; chemical preparations for pharmaceutical purposesfor geneticcardiovascularcentral nervous systemendocrinegastrointestinalhepaticbiliaryimmunologicalallergicpulmonarydermatologicalinfectiousinflammatorymenopausalnutritionalmetabolicdiabetesautoimmunemusculoskeletalconnective tissueneurologicalophthalmologicpsychiatricrespiratoryurogenitalurologicalerectile dysfunctionsexual dysfunctiongynecologyobstetricpediatrichematologiconcologicalfungal and viral diseases and disorders; diagnostic preparations for medical use; diagnostic reagents for medicinal use; preparations for destroying vermin; fungicidesherbicides
Classe 35
Retail and wholesale servicesretail and wholesale stores featuring pharmaceutical preparationsmedicinesmedicalsurgical and dental apparatus and instrumentsnutritional supplementsvitaminsmineral supplements; advertising and business management services; business management; providing office functions; import agencies; sales promotion services; business consulting services; business information services; public relations services; electronic commerce servicesproviding information about products via telecommunication networks for advertising and sales purposes; purchase and rental of advertising space; direct mail advertising; business networking; arranging of business introductions; conducting of exhibitions for business purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
24/07/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
21/02/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/04/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
03/10/2023
C71T
CANCELLED SECTION 71
03/02/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
20/10/2022
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
21/08/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
13/11/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
25/08/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/12/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
20/11/2016
FIMP
FINAL DISPOSITION PROCESSED
20/11/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/10/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
19/07/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/07/2016
PUBO
PUBLISHED FOR OPPOSITION
03/05/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/04/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
13/04/2016
NPUB
NOTICE OF PUBLICATION
13/04/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/03/2016
CNEA
EXAMINERS AMENDMENT MAILED
30/03/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
29/03/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/03/2016
RDX2
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED MAILED
15/03/2016
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
14/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/03/2016
CNFR
FINAL REFUSAL MAILED
21/01/2016
CNFR
FINAL REFUSAL WRITTEN
20/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/12/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/12/2015
RFNT
REFUSAL PROCESSED BY IB
18/07/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/07/2015
RFRR
REFUSAL PROCESSED BY MPU
01/07/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/07/2015
CNRT
NON-FINAL ACTION WRITTEN
30/06/2015
MAFR
APPLICATION FILING RECEIPT MAILED
30/06/2015
DOCK
ASSIGNED TO EXAMINER
27/06/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/06/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/06/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CARTIHEAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.